The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.70
Bid: 8.50
Ask: 8.90
Change: 0.76 (9.57%)
Spread: 0.40 (4.706%)
Open: 8.25
High: 8.70
Low: 8.25
Prev. Close: 7.94
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intellectual Property Update

6 Mar 2024 07:00

RNS Number : 7248F
MicroSalt PLC
06 March 2024
 

 

6 March 2024

MicroSalt plc

("MicroSalt" or the "Company")

 

Intellectual Property ("IP") Update

 

MicroSalt plc, (AIM: SALT) a company producing full-flavour, low-sodium salt for food manufacturers and consumers, is pleased to announce that it has received a Notice of Allowance from the United States Patent and Trademark Office for Patent Application No. 18/175,028.

 

The Patent Application entitled Low Sodium Salt Composition, concerns the production of MicroSalt, a low-sodium salt that adheres better to foods than a traditional salt (which is not adhered to a carrier particle).

 

Receipt of a Notice of Allowance indicates that the claims in the patent application are patentable. MicroSalt expect the patent will be granted upon completion of certain administrative matters in short course. Once granted, the patent is expected to expire in 2039.

 

This Notice of Allowance relates to one of the 14 pending patent applications described in the Company's admission document dated 27 January 2024. MicroSalt also has counterpart patent applications with claims directed to similar subject matter as the Patent Application 18/175,028 pending in countries including China, Chile, Australia, Brazil, Europe, Canada, Japan, Russia, Mexico, India and Hong Kong.

 

MicroSalt also owns a previously issued United States patent directed to its salt carrier product and production processes, and a United States provisional patent application directed to additional innovations.

 

Rick Guiney, CEO of Microsalt, said:

 

"This Notice of Allowance further strengthens our IP position in the global low sodium market whilst providing additional evidence of our thought leadership position in the battle to lower sodium consumption worldwide."

 

 For more information, please visit www.microsaltinc.co, follow on X @microSaltPLC or contact:

 

MicroSalt plc

Via Flagstaff

Rick Guiney, CEO 

 

 

Zeus (Nominated Adviser and Broker)

David Foreman / James Edis (Investment Banking)

Dom King (Corporate Broking), Rupert Woolfenden (Sales)

 

+44 (0)20 3829 5000

Flagstaff PR (Financial IR/FPR)  

+44 (0)20 7129 1474

Tim Thompson / Alison Allfrey / Anna Probert

microsalt@flagstaffcomms.com

 

 

Notes to Editors

 

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.

 

MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

 

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70% of the typical person's sodium intake is hidden in processed foods.

 

Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market.

 

The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUVUORSRUORUR
Date   Source Headline
2nd Aug 20194:15 pmRNSHolding(s) in Company
1st Aug 201911:35 amRNSHolding(s) in Company
1st Aug 201911:34 amRNSHolding(s) in Company
25th Jul 20197:00 amRNSInvestor Conference Call
22nd Jul 20197:00 amRNSExpansion of Tekcapital services in Mexico
16th Jul 20197:00 amRNSNotice of Investor Conference Call
11th Jul 20197:00 amRNSPlacing to raise £0.75 million
27th Jun 20197:00 amRNSGuident Acquires Additional IP
26th Jun 20197:00 amRNSBelluscura likely to receive FDA clearance in 2019
25th Jun 20197:00 amRNSGuident Acquires Additional IP
24th Jun 20197:00 amRNSSalarius Secures New Order for MicroSalt®
13th Jun 20197:00 amRNSSalarius Secures & Delivers Follow-on Order
14th May 20197:00 amRNSLucyd Launches Loud 2.0 Eyewear Line
3rd May 20197:00 amRNSFlorida Legislature Approves Autonomous Vehicles
29th Apr 20197:00 amRNSGuident Files Additional Patent
24th Apr 20197:00 amRNSPortfolio company, Belluscura plc, raises £500,730
23rd Apr 201911:05 amRNSSecond Price Monitoring Extn
23rd Apr 201911:00 amRNSPrice Monitoring Extension
23rd Apr 20197:00 amRNSSalarius secures first commercial order
5th Apr 20193:12 pmRNSResult of AGM
2nd Apr 20197:00 amRNSStrategic Alliance Agreement with Emprende UP
1st Apr 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSAttendance at UK Investor Show
14th Mar 20197:00 amRNSInvestor conference call
14th Mar 20197:00 amRNSPosting of Annual Report and Notice of AGM
1st Mar 20195:26 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSUpdate of Research Coverage
26th Feb 20197:00 amRNSNotice of Investor Conference Call
25th Feb 20197:00 amRNSFull Year 2018 Preliminary Results
21st Feb 20197:00 amRNSLucyd Provides Market Update
21st Feb 20197:00 amRNSNotice of Preliminary Results Announcement
19th Feb 20198:52 amRNSBelluscura Files Additional Patent
15th Feb 20193:26 pmRNSHolding(s) in Company
30th Jan 20199:23 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSGuident Ltd Appoints Director
17th Dec 20184:36 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSUniversity IP webinar
6th Dec 20187:00 amRNSGuident Ltd Appoints Director
3rd Dec 20187:00 amRNSLucyd Signs R Sherman as Chief Brand Officer
26th Nov 20187:00 amRNSMello London
14th Nov 20187:00 amRNSLucyd Launches Affiliate and Reseller Program
8th Nov 201811:34 amRNSHolding(s) in Company
19th Oct 20181:52 pmRNSHolding(s) in Company
18th Oct 20185:25 pmRNSHolding(s) in Company
16th Oct 20185:02 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSPortfolio Company Update
9th Oct 20187:00 amRNSExecutive Appointment
5th Oct 20187:00 amRNSScience Advisor Appointment
3rd Oct 20187:00 amRNSPublication of Research Note

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.